SDHA encodes a mitochondrial enzyme; its amplification may alter cellular metabolism through changes in succinate and α-ketoglutarate levels, potentially influencing the activity of epigenetic regulators such as TET2 and ASXL1, and immune modulation within the tumor microenvironment. The gene discussed is ASXL1; the disease is neoplasm.